首页> 外文OA文献 >The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients

【2h】

The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients

机译：EBV DNA在固体器官和造血干细胞移植受体中移植后淋巴抑制性疾病的早期检测

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Neval E. Wareham; Amanda Mocroft; Henrik Sengeløv; Caspar Da Cunha-Bang; Finn Gustafsson; Carsten Heilmann; Martin Iversen; Nikolai S. Kirkby; Allan Rasmussen; Søren Schwartz Sørensen; Jens D. Lundgren;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients [J] . Wareham Neval E., Mocroft Amanda, Sengelov Henrik, Journal of Cancer Research and Clinical Oncology . 2018,第8期

机译：EBV DNA在固体器官和造血干细胞移植受者的移植后淋巴抑制性疾病的早期检测
2. Adoptive Therapy with EBV-Specific T Cells for Treatment of CNS EBV Post-Transplant Lymphoproliferative Disease Arising after Hematopoietic Stem Cell Transplant or Solid Organ Transplant [J] . Prockop Susan, Suser Stephanie, Doubrovina Ekaterina, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：用EBV特异性T细胞的采用疗法治疗造血干细胞移植或固体器官移植后产生的CNS EBV后移植后淋巴抑制性疾病
3. Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation [J] . Jiang Xinmiao, Xu Lanping, Zhang Yu, Oncoimmunology. . 2016,第5期

机译：基于Rituximab的治疗，然后是通过对组织造血干细胞移植接受者进行活组织检查证明的EBV相关的移植后移植后淋巴抑制性疾病的养殖疗法
4. Circulating Tumor DNA Predicts Post-Allogeneic Hematopoietic Stem Cell Transplantation in AML and MDS [C] . Sousuke Nakamura International Molecular Medicine Tri-Conference. . 2019

机译：循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
5. Plasma Cell Myeloma and Plasmacytoma-like Post-transplant Lymphoproliferative Disorders: A Survival Analysis in the Scientific Registry of Transplant Recipients. [D] . Rosenberg, Aaron. 2014

机译：浆细胞骨髓瘤和类浆细胞瘤样移植后淋巴组织增生性疾病：移植受体科学注册中的生存分析。
6. Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation [O] . Xinmiao Jiang, Lanping Xu, Yu Zhang, 2016

机译：在接受异基因造血干细胞移植的患者中以利妥昔单抗为基础的治疗然后采用过继细胞免疫疗法针对活检证实的EBV相关的移植后淋巴增生性疾病
7. 29P ALLELE study: A multicenter, open label, phase III study of tabelecleucel for solid organ or allogeneic hematopoietic cell transplant subjects with Epstein-Barr virus-driven post-transplant lymphoproliferative disease (EBV+ PTLD) after failure of rituximab or rituximab and chemotherapy [O] . N. Worel, J.A. Perez-Simon, P. Barba, 2020

机译：29P等级研究：多中心，开放标签，塔伯列皮葡萄酒术的三期研究，用于固体器官或同种异体造血细胞移植受试者，其在Rituximab或Rituximab和化疗失败后的Epstein-Barr病毒驱动后移植后移植后淋巴抑制性疾病（EBV + PTLD）

The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients

著录项

引文网络

相似文献

相关主题

期刊订阅